Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Jan-20 1:25 PM View:  | Denner Alexander J Director | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 4,202,000 | -- | -- | (100%) 4.2M to 0 | |
| 06-Jan-20 1:26 PM View: | Germano Geno J Director | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 7,429 | -- | -- | (100%) 7.43K to 0 | |
| 06-Jan-20 1:30 PM View: | Schlesinger Sarah J. Director | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 7,429 | -- | -- | (100%) 7.43K to 0 | |
| 06-Jan-20 1:31 PM View: | Timney Mark Chief Executive Officer Director | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 185,415 | -- | -- | (100%) 185.41K to 0 | |
| 06-Jan-20 1:29 PM View: | Rodin Stephen M EVP and General Counsel | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 84,782 | -- | -- | (100%) 84.78K to 0 | |
| 06-Jan-20 1:32 PM View: | Visioli Christopher Chief Financial Officer | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 68,843 | -- | -- | (100%) 68.84K to 0 | |
| 06-Jan-20 1:27 PM View: | Kelly John C. Director | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 32,148 | -- | -- | (100%) 32.15K to 0 | |
| 06-Jan-20 1:28 PM View: | Meanwell Clive Chief Innovation Officer Director | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 480,340 | -- | -- | (100%) 480.34K to 0 | |
| 06-Jan-20 1:25 PM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 85,813 | -- | -- | (2%) 4.29M to 4.2M | |
| 06-Jan-20 1:33 PM View: | Wijngaard Peter Chief Development Officer | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 107,546 | -- | -- | (100%) 107.55K to 0 | |
| 06-Jan-20 1:29 PM View: | Panayiotopoulos Paris Director | Medicines Co. (MDCO) | 06-Jan-20 | Disposition | 13,881 | -- | -- | (100%) 13.88K to 0 | |
| 31-Dec-19 7:54 PM View: | Rodin Stephen M EVP and General Counsel | Medicines Co. (MDCO) | 27-Dec-19 | Payment of Exercise | 138,522 | $84.78 | $11,743,900.00 | (62%) 223.3K to 84.78K | |
| 31-Dec-19 7:54 PM View: | Meanwell Clive Chief Innovation Officer Director | Medicines Co. (MDCO) | 27-Dec-19 | Option Exercise | 541,671 | $19.44 | $10,528,100.00 | 186% 290.81K to 832.48K | |
| 31-Dec-19 7:55 PM View: | Wijngaard Peter Chief Development Officer | Medicines Co. (MDCO) | 27-Dec-19 | Payment of Exercise | 224,341 | $84.78 | $19,019,600.00 | (68%) 331.89K to 107.55K | |
| 31-Dec-19 7:55 PM View: | Visioli Christopher Chief Financial Officer | Medicines Co. (MDCO) | 27-Dec-19 | Payment of Exercise | 130,536 | $84.78 | $11,066,800.00 | (65%) 199.38K to 68.84K | |
| 31-Dec-19 7:55 PM View: | Wijngaard Peter Chief Development Officer | Medicines Co. (MDCO) | 27-Dec-19 | Option Exercise | 329,439 | $31.49 | $10,372,700.00 | 13457% 2.45K to 331.89K | |
| 31-Dec-19 7:55 PM View: | Visioli Christopher Chief Financial Officer | Medicines Co. (MDCO) | 27-Dec-19 | Option Exercise | 192,127 | $29.43 | $5,654,400.00 | 2649% 7.25K to 199.38K | |
| 31-Dec-19 7:55 PM View: | Timney Mark Chief Executive Officer Director | Medicines Co. (MDCO) | 27-Dec-19 | Payment of Exercise | 249,865 | $84.78 | $21,183,600.00 | (57%) 435.28K to 185.41K | |
| 31-Dec-19 7:54 PM View: | Rodin Stephen M EVP and General Counsel | Medicines Co. (MDCO) | 27-Dec-19 | Option Exercise | 194,097 | $32.74 | $6,355,310.00 | 665% 29.21K to 223.3K | |
| 31-Dec-19 7:54 PM View: | Meanwell Clive Chief Innovation Officer Director | Medicines Co. (MDCO) | 27-Dec-19 | Payment of Exercise | 352,141 | $84.78 | $29,854,500.00 | (42%) 832.48K to 480.34K | |
| 31-Dec-19 7:55 PM View: | Timney Mark Chief Executive Officer Director | Medicines Co. (MDCO) | 27-Dec-19 | Option Exercise | 405,000 | $84.78 | $34,335,900.00 | 1338% 30.28K to 435.28K | |
| 04-Sep-19 4:21 PM View: | Meanwell Clive Chief Innovation Officer Director | Medicines Co. (MDCO) | 30-Aug-19 | Grant | 491 | $21.60 | $10,605.60 | < 1% 290.32K to 290.81K | |
| 04-Sep-19 4:22 PM View: | Wijngaard Peter Chief Development Officer | Medicines Co. (MDCO) | 30-Aug-19 | Grant | 491 | $21.60 | $10,605.60 | 25% 1.96K to 2.45K | |
| 04-Sep-19 4:22 PM View: | Timney Mark Chief Executive Officer Director | Medicines Co. (MDCO) | 30-Aug-19 | Grant | 491 | $21.60 | $10,605.60 | 2% 29.79K to 30.28K | |
| 04-Sep-19 4:23 PM View: | Rodin Stephen M EVP and General Counsel | Medicines Co. (MDCO) | 30-Aug-19 | Grant | 491 | $21.60 | $10,605.60 | 2% 28.14K to 28.63K | |
| 06-Aug-19 5:54 PM View: | Rodin Stephen M EVP and General Counsel | Medicines Co. (MDCO) | 02-Aug-19 | Option Sale | 5,000 | $34.82 | $174,100.00 | (15%) 33.14K to 28.14K | |
| 06-Aug-19 5:54 PM View: | Rodin Stephen M EVP and General Counsel | Medicines Co. (MDCO) | 02-Aug-19 | Option Exercise | 5,000 | $8.38 | $41,900.00 | 18% 28.14K to 33.14K | |
| 28-Jun-19 8:19 PM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 28-Jun-19 | Private Purchase | 50,000 | $33.00 | $1,650,000.00 | 1% 4.17M to 4.22M | |
| 03-Jun-19 5:17 PM View: | Kelly John C. Director | Medicines Co. (MDCO) | 30-May-19 | Grant | 3,663 | -- | -- | 13% 28.48K to 32.15K | |
| 31-May-19 7:31 AM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 30-May-19 | Market Purchase | 50,000 | $34.81 | $1,740,500.00 | 1% 4.1M to 4.15M | (< 1%) |
| 03-Jun-19 5:09 PM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 30-May-19 | Grant | 3,663 | -- | -- | < 1% 4.16M to 4.17M | |
| 03-Jun-19 5:13 PM View: | Panayiotopoulos Paris Director | Medicines Co. (MDCO) | 30-May-19 | Grant | 3,663 | -- | -- | 36% 10.22K to 13.88K | |
| 03-Jun-19 5:23 PM View: | Germano Geno J Director | Medicines Co. (MDCO) | 30-May-19 | Grant | 3,663 | -- | -- | 97% 3.77K to 7.43K | |
| 03-Jun-19 5:11 PM View: | Schlesinger Sarah J. Director | Medicines Co. (MDCO) | 30-May-19 | Grant | 3,663 | -- | -- | 97% 3.77K to 7.43K | |
| 31-May-19 7:31 AM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 29-May-19 | Market Purchase | 35,000 | $34.85 | $1,219,750.00 | < 1% 4.07M to 4.1M | (< 1%) |
| 22-May-19 5:56 PM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 22-May-19 | Market Purchase | 139,000 | $33.13 | $4,605,070.00 | 4% 3.93M to 4.07M | 2% |
| 22-May-19 5:56 PM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 21-May-19 | Market Purchase | 132,000 | $33.95 | $4,481,400.00 | 3% 3.8M to 3.93M | (< 1%) |
| 22-May-19 5:56 PM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 20-May-19 | Market Purchase | 160,000 | $34.50 | $5,520,000.00 | 4% 3.64M to 3.8M | (2%) |
| 26-Apr-19 4:33 PM View: | Meanwell Clive Chief Innovation Officer Director | Medicines Co. (MDCO) | 25-Apr-19 | Payment of Exercise | 2,796 | $30.48 | $85,222.10 | (< 1%) 293.12K to 290.32K | 2% |
| 08-Mar-19 1:13 PM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 06-Mar-19 | Market Purchase | 248,100 | $24.91 | $6,180,170.00 | 7% 3.39M to 3.64M | (2%) |
| 05-Mar-19 5:14 PM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 05-Mar-19 | Market Purchase | 181,900 | $26.07 | $4,742,130.00 | 6% 3.21M to 3.39M | (< 1%) |
| 06-Mar-19 6:27 PM View: | Meanwell Clive Chief Innovation Officer Director | Medicines Co. (MDCO) | 04-Mar-19 | Payment of Exercise | 9,611 | $25.53 | $245,369.00 | (3%) 302.73K to 293.12K | (2%) |
| 06-Mar-19 6:25 PM View: | Cox Christopher T EVP & Chief Corp. Dev. Officer | Medicines Co. (MDCO) | 04-Mar-19 | Payment of Exercise | 2,638 | $25.53 | $67,348.10 | (< 1%) 395.58K to 392.94K | (2%) |
| 06-Mar-19 6:30 PM View: | Rodin Stephen M EVP and General Counsel | Medicines Co. (MDCO) | 04-Mar-19 | Payment of Exercise | 1,752 | $25.53 | $44,728.60 | (6%) 29.89K to 28.14K | (2%) |
| 05-Mar-19 5:14 PM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 04-Mar-19 | Market Purchase | 325,000 | $25.45 | $8,271,250.00 | 11% 2.88M to 3.21M | 2% |
| 06-Mar-19 6:28 PM View: | Visioli Christopher Chief Financial Officer | Medicines Co. (MDCO) | 04-Mar-19 | Payment of Exercise | 909 | $25.53 | $23,206.80 | (11%) 8.16K to 7.25K | (2%) |
| 05-Mar-19 5:14 PM View: | Denner Alexander J Director | Medicines Co. (MDCO) | 01-Mar-19 | Market Purchase | 100,000 | $25.15 | $2,515,000.00 | 4% 2.78M to 2.88M | 3% |
| 04-Mar-19 4:23 PM View: | Meanwell Clive Chief Innovation Officer Director | Medicines Co. (MDCO) | 28-Feb-19 | Grant | 317 | $20.97 | $6,647.49 | < 1% 302.41K to 302.73K | |
| 04-Mar-19 4:24 PM View: | Rodin Stephen M EVP and General Counsel | Medicines Co. (MDCO) | 28-Feb-19 | Grant | 317 | $20.97 | $6,647.49 | 1% 29.57K to 29.89K | |
| 04-Mar-19 4:25 PM View: | Cox Christopher T EVP & Chief Corp. Dev. Officer | Medicines Co. (MDCO) | 28-Feb-19 | Grant | 317 | $20.97 | $6,647.49 | < 1% 395.26K to 395.58K |
